Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.
Atia O, Orlanski-Meyer E, Lujan R, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Gabay H, Matz E, Nevo D, Israeli E, Schwartz D, Chowers Y, Dotan I, Turner D. Atia O, et al. J Crohns Colitis. 2022 Jun 24;16(5):778-785. doi: 10.1093/ecco-jcc/jjab204. J Crohns Colitis. 2022. PMID: 34791083
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN.
Atia O, Orlanski-Meyer E, Lujan R, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Gabay H, Matz E, Nevo D, Ollech J, Zittan E, Israeli E, Schwartz D, Chowers Y, Dotan I, Turner D. Atia O, et al. J Crohns Colitis. 2022 Jun 24;16(5):796-803. doi: 10.1093/ecco-jcc/jjab210. J Crohns Colitis. 2022. PMID: 34904163
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN).
Atia O, Focht G, Lujan R, Ledder O, Greenfeld S, Kariv R, Dotan I, Yanai H, Gabay H, Balicer R, Haklai Z, Nevo D, Turner D. Atia O, et al. J Pediatr Gastroenterol Nutr. 2022 Jun 1;74(6):788-793. doi: 10.1097/MPG.0000000000003422. Epub 2022 Feb 22. J Pediatr Gastroenterol Nutr. 2022. PMID: 35192577
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix.
Atia O, Pujol-Muncunill G, Navas-López VM, Orlanski-Meyer E, Ledder O, Lev-Tzion R, Focht G, Shteyer E, Stein R, Aloi M, Russell RK, Martin-de-Carpi J, Turner D. Atia O, et al. Aliment Pharmacol Ther. 2022 Sep;56(5):794-801. doi: 10.1111/apt.17092. Epub 2022 Jun 23. Aliment Pharmacol Ther. 2022. PMID: 35735987 Free PMC article.
35 results